Table 1.
Baseline features of Patients with Re-Operation.
| Recurrence | No Evidence of Tumor | p value | |
|---|---|---|---|
| Number (n) | 27 | 11 | |
| Age (Mean) [Range] | 57.1 [35-76] | 52.9 [32-71] | 0.310 |
| Gender | 0.283 | ||
| Female | 8 | 6 | |
| Male | 19 | 5 | |
| Histology | 0.932 | ||
| WHO Grade 2 | 8 | 3 | |
| WHO Grade 3 | 2 | 1 | |
| WHO Grade 4 | 17 | 7 | |
| Usage of foreign material (n, %) | |||
| Tabotamp® | 20 (74.1 %) | 10 (90.9 %) | 0.627 |
| TachoSil® | 6 (22.2 %) | 1 (9.1 %) | 0.627 |
| Gelita® | 3 (11.1 %) | 0 (0 %) | 0.625 |
| No foreign material | 3 (11.1 %) | 0 (0 %) | 0.436 |
| Time to second surgery (days, median) [Range] | 383 [64-2969] | 184 [5-2872] | 0.633 |
| Prior Chemotherapy | 18 (66.6 %) | 8 (72.7 %) | 1.0 |
| Prior Radiation | 20 (74.1 %) | 8 (72.7 %) | 1.0 |
| ADC values (mm2/s x 10.−6) [SD] | 812.60 [142.2] | 673.87 [86.8] | 0.52 |